05 December,2023 07:38 AM IST | New Delhi | IANS
Image for representational purposes only. Photo Courtesy: iStock
More than 40 companies manufacturing cough syrups in the country have failed quality tests, a CDSCO report said citing the lab tests conducted in different states in the aftermath of reports linking India-made cough syrups to 141 child fatalities globally.
As per the report released by the Central Drugs Standard Control Organisation (CDSCO), out of 1,105 samples tested, 59 samples were declared as 'not of standard quality'.
The report was released by the CDSCO in November under a list of drugs, medical devices and cosmetics declared as 'not of standard quality' or 'spurious' or 'adulterated' or 'misbranded'.
The data has come from the test reports of government testing labs. The report said that no samples were found to be spurious or misbranded.
ALSO READ
The kids aren’t alright: Experts dissect the impact of social media on children
Look at how some of Trump's picks to lead health agencies could help carry out Kennedy's overhaul
Health paramount, guard it to become developed country: VP Jagdeep Dhankhar
Here’s how you can feel energetic in the morning, according to Rujuta Diwekar
Five gynaecological cancers that every woman should be aware of
The move came after several deaths were reported globally post consuming India-made cough syrups. The Directorate General of Foreign Trade (DGFT) after these deaths had made it mandatory for exporters to seek government clearance on the quality of cough syrups.
Noting the DGFT requirement, CDSCO has been testing all the batches of cough syrups which seek export permission.
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever
